The effects of nose flap devices in calves before dam separation on cow BCS, pre-and postseparation calf performance, and humoral immune response were compared with traditional weaning. Primiparous and multiparous Angus and Hereford cows (n = 113) and their Angus, Hereford, and Angus × Hereford calves (179.4 ± 3.92 kg and 161 ± 22.7 d of age) were used. Cow-calf pairs were allocated to 1 of 2 treatments in a completely randomized design: 1) nose flap for 21 d before separation from the dam (NF) or 2) no nose flap for 21 d before separation from the dam (CON). Calves were separated from dams on d 0, and calves were placed in group feed-yard pens for 28 d. A subset (n = 75) of weaned calves were placed into 1 of 8 pens to evaluate DMI. Cow BCS was measured on d -21 and 56, and calves were given modified live vaccinations (d -21 and 1), challenged with ovalbumin (OVA; d 1), and weighed (d -21, 1, 7, 14, 21, and 28). In addition, blood samples were collected (d -21, 1, 14, and 28) to measure primary humoral immune response. Control calves tended to have greater BW on d 14 (P = 0.09) and 21 (P = 0.07) than NF calves, and CON calves had greater (P < 0.05) ADG from d -21 to 1 vs. NF calves. Treatments did not differ (P ≥ 0.27) for postweaning DMI, G:F, or morbidity. Serum neutralization tests for bovine viral diarrhea virus type 1 (BVDV-1) and bovine herpesvirus type 1 (BHV-1) were used to measure humoral response to a viral vaccination. Serum antibody titers to BVDV-1 for CON calves tended (P = 0.08) to be greater on d 1 and were greater (P < 0.05) by d 28 vs. NF calves. By d 28, a greater percentage (P < 0.05) of CON calves seroconverted for BVDV-1 than NF calves (82.1 vs. 66.7%, respectively). Serum antibody titers for BHV-1 were greater (P < 0.05) on d 1 and 28 for CON vs. NF calves. Humoral immune response to OVA during the 28-d postseparation period from the dam was evaluated in a subset (n = 57) of calves. There was no difference (P = 0.92) in OVA-specific IgG between treatments on d 14 or 28 (P = 0.76); however, OVA-specific IgM was greater (P < 0.05) in CON vs. NF calves on d 28. Results indicate that nose flap devices did not influence feed intake, feed efficiency, or morbidity during the initial postseparation period from the dam. However, preweaning ADG, serum BVDV-1 and BHV-1 titers, and humoral immune response to OVA were decreased in calves that received the nose flap treatment.
INTRODUCTION
reported decreased lymphocyte blastogenic responses in calves experiencing transportation stress, indicating that stress can cause immunosuppression and increased disease susceptibility. Lymphocytes increase in response to infection and help the body produce an immune response necessary to respond to a vaccination or infection (Murphy et al., 2011) . Abrupt weaning can also reduce immune function through decreased lymphocytes and neutrophils (Lynch et al., 2010) . Increased incidence of stress-induced disease disrupts an animal's well-being, and it is detrimental to the beef industry, as feed yard steers treated for disease have reduced performance (Schneider et al., 2009) .
Minimizing stress associated with weaning may improve the effectiveness of vaccines. Two-stage weaning strategies may serve as a low-stress weaning method by allowing the calf to begin to break the social bond with the dam before physical separation (Haley et al., 2005; Lambertz et al., 2014) . Fence-line weaning decreased morbidity rates to 15% compared with 28% for traditionally weaned calves (Boyles et al., 2007) . Proactive calf vaccination protocols include a vaccine administered 2 to 3 wk before weaning and a booster vaccine administered at weaning. A 2-stage weaning protocol with nose flaps, which are devices inserted into a calf's nose for a short time before calf removal from the dam, prevents nursing while allowing a calf to graze and drink and can be matched with a preweaning vaccination program without adding additional calf handling interventions.
Our hypothesis was that nose flap devices used before weaning are a low-stress alternative to traditional weaning and would improve vaccine effectiveness without negatively impacting performance after separation from the dam. The objective of this study was to evaluate the effects of nose flap weaning devices on cow performance, calf performance before and after separation from the dam, and calf humoral immune response.
MATERIALS AND METHODS

Experimental Design and Treatments
This experiment was conducted following approval by the Colorado State University (CSU) Animal Care and Use Committee. One hundred thirteen Angus, Hereford, and Angus × Hereford calves (n = 56 bulls and n = 57 heifers) and their primiparous and multiparous purebred Angus and Hereford dams from the CSU Agricultural, Research, Development, and Education Center seed stock herd were used in this experiment. All cows remained in a single 283-ha native range mountain pasture near Kremmling, CO, throughout the course of the experiment, and calves remained in this pasture until separation from dams. No supplement beyond trace mineralized salt was provided while cattle were on pasture during the experiment. Before the study, all calves received a clostridial antigen vaccination (Ultrabac 7; Zoetis Inc., Florham Park, NJ), and a modified live intranasal vaccine containing bovine respiratory syncytial virus, infections bovine rhinotracheitis virus, and parainfluenza-3 virus (Inforce 3; Zoetis Inc.) on d -96 (63 ± 22.7 d of age). Calves also received a clostridial vaccine booster (Ultrabac 7; Zoetis Inc.) and a single dose of a vaccine containing bovine rhinotracheitis, bovine viral diarrhea virus, parainfluenza 3, and bovine respiratory syncytial virus (Bovi-Shield GOLD 5; Zoetis Inc.) on d -68.
The experiment was a completely randomized design so that calf BW at 114 ± 22.7 d of age, breed, and gender were evenly distributed among treatments. Cow-calf pairs were allotted to 1 of 2 treatments: 1) nose flap for 21 d before separation from the dam (NF) or 2) no nose flap for 21 d before separation from the dam (CON). Cow parity was not intentionally balanced across treatments, although the number of primiparous females was equivalent between treatments (n = 16 for NF and n = 23 for CON). On d -21, all calves (161 ± 22.7 d of age) were weighed, and calves assigned to the NF treatment were fitted with QuietWean NF (JDA Livestock Innovations Ltd., Saskatchewan, Canada) before returning all calves to their dams. In addition, blood samples were collected from all calves via jugular venipuncture into individually marked vacuum tubes (Vacutainer; Becton, Dickinson and Company, Franklin Lakes, NJ) on d -21, 1, 14, and 28. Samples were transported to the laboratory on ice and allowed to coagulate overnight in a refrigerator at 5°C. The following day, blood samples were centrifuged at room temperature (25°C) at 1,000 × g for 10 min to separate serum. Serum was removed, placed into a sterile tube labeled with animal identification and day, and stored at -20°C until processing. Samples were used for evaluation of humoral immune response.
On d 0, cow-calf pairs were gathered and calves were separated from their dams. All calves were then transported approximately 3.5 h (257 km) back to the CSU feed yard research facility. After an overnight rest period, on d 1, all calves were weighed, bled, and administered a booster vaccine (Bovi-Shield GOLD 5; Zoetis Inc.). To measure feed intake and efficiency, a subset (n = 75) of calves was assigned to 1 of 8 pens (4 pens/treatment; 2 pens with bulls and 2 pens with heifers within each treatment). Calves excessively greater or lower than the mean BW were commingled by gender and treatment in 1 of 4 group pens (1 pen per treatment × gender combination), and data from these calves were included in calf performance and morbidity but not included for feed intake or efficiency evaluation. Calf BW was collected on d 7, 14, 21, and 28 using an electronic scale.
For the purpose of the study, calves were revaccinated with a modified live vaccine containing bovine rhinotracheitis, bovine viral diarrhea virus, parainfluenza 3, and bovine respiratory syncytial virus (Bovi-Shield GOLD 5; Zoetis Inc.) on d -21 and 1. Vaccination storage, handling, and administration protocols consistent with Beef Quality Assurance guidelines (BQA, 2010) were followed, as vaccines stayed within an insulated container when not in use and small amounts were mixed at a time.
Calves received a receiving ration on entering the feed yard (Table 1) . During the first week, supplemental grass hay was included in the ration. Orts were collected weekly, dried, weighed, and subtracted from the amount fed to calculate DMI. Trained staff monitored calves daily for signs of morbidity as described by Berry et al. (2004) . Treatment records were collected and analyzed for calves treated either once or 2 or more times for respiratory illness. After the 28-d receiving period, heifer calves were commingled with each other and bull calves were commingled with each other.
Cow performance variables evaluated herein included BCS, as described by Wagner et al. (1988) and averaged between 2 data collectors, collected on d -21 and 56 and pregnancy rate to a synchronized AI measured in the subsequent year. Due to culling and allocation of numerous cows to other non-AI breeding strategies, including use as recipient dams in an embryo transfer program, only those cows subjected to AI (n = 55; representing 26 to 29 cows from each calf weaning treatment) the following year were used to evaluate subsequent reproductive performance due to calf treatment. Estrus was synchronized in these cows beginning 10 d before timed AI and included administration of GnRH (100 μg; i.m.; Factrel; Zoetis Inc.) with controlled internal drug release (CIDR; EaziBreed CIDR, 1.38 g progesterone; Zoetis Inc.) insertion 7 d before administration of PGF 2α (25 mg; i.m.; Lutalyse; Zoetis Inc.) and CIDR removal. Estrus detection patches (Estrotect; Western Point, Inc., Apple Valley, MN) were also administered at the time of CIDR removal. Depending on patch status at 65 h after PGF 2α administration, timed AI was administered at either 65 (for cows with tripped patches) or 84 h (for cows with nontripped patches) after PGF 2α administration along with GnRH (100 μg; i.m.; Factrel; Zoetis Inc.). Beginning 9 d later, cows were placed with bulls and pregnancy to AI was determined 35 d after AI via transrectal ultrasonography.
Serum Neutralization
Serum neutralization tests against bovine viral diarrhea virus type 1 (BVDV-1; CSU National Veterinary Services Laboratory 140BVD9701) and bovine herpesvirus type 1 (BHV-1; CSU Cooper strain) were completed to analyze serum titers and evaluate humoral response to a viral vaccination. Tests were conducted at the CSU Veterinary Diagnostic Laboratory using the procedure described by Bolin and Ridpath (1990) . Briefly, serum was heat inactivated at 56°C for 30 min. Minimal essential medium was added to 96-well sterile culture plates followed by positive control antiserum and serum sample. Each sample was completed singularly within a single plate in 2-fold dilutions from 1:8 to 1:4,096 for bovine viral diarrhea virus (BVDV) and 1:2 to 1:1,024 for BHV-1. Virus diluted to 100 μL of 50% tissue culture infective dose was added to each well and allowed to incubate for 1 h in a 37°C CO 2 cell culture incubator. After incubation, 150 μL of cell suspension was added to each well and again allowed to incubate in a 37°C CO 2 cell culture incubator. Following 3 d of incubation, cells were observed for cytopathic effect (CPE). Titers were reported as log2 transformation of the reciprocal of the average greatest dilution that observed no CPE. A 0 antibody concentration was reported for serum that showed CPE at 1:2 dilution for BHV-1 and 1:8 dilution for BVDV. Seroconversion was defined as a 4-fold increase in serum titer concentration compared with d -21 titers (Nauta, 2010) .
Ovalbumin Challenge
A subset (n = 57) of calves selected based on calf BW at d -21, breed, age, gender, and treatment were injected with ovalbumin (OVA) to elicit a primary response to a secondary antigen on d 1 and examine humoral immune response to a foreign protein immediately after separation from the dam. A solution containing 160 mg OVA (Sigma A5503; Sigma-Aldrich, St. Louis, MO), 60 mL Freund's Incomplete Adjuvant (Sigma F-5506; Sigma-Aldrich), and 60 mL of PBS was prepared. Two milliliters of this solution was injected s.c. and 1 mL i.m. providing a total dose of 4,000 μg of OVA per animal (Dorton et al., 2003) .
Analyses of serum antibody titers specific to OVA were conducted using the ELISA procedure described by Engvall and Perlmann (1972) . Ninety-six-well sterile culture plates were coated with OVA and incubated at 4°C for at least 18 h. Ovalbumin was aspirated from each well and washed with a solution composed of Tris-buffered saline and Tween 20 (TBST) a total of 3 times. Two hundred microliters of TBST was added to each well and incubated at 21°C for a minimum of 1 h. Plates were aspirated, washed once, and filled with 100 μL of serum diluted with TBST. After 1 h incubation at 21°C, wells were aspirated and washed 5 times. One hundred microliters of OVA-specific IgG or IgM were added to each well and incubated at 21°C for 1 h. After incubation, wells were aspirated and washed an additional 5 times. To detect antibodies, 100 μL of enzyme substrate was added to each well. To stop the reaction, 100 μL of H 2 SO 4 was added to each well. Plates were read at 450 nm using a microtiter plate reader to observe serum OVA IgG and IgM concentrations. Titers were reported as log10 transformation of the reciprocal of the average greatest dilution.
Statistical Analyses
Data were analyzed as a completely randomized design using the MIXED procedure of SAS (version 9.2; SAS Inst. Inc., Cary, NC) with cow or calf as the experimental unit for cow BCS, calf BW, calf ADG, and serum titer concentration for BVDV-1, BHV-1, and OVA. Data were analyzed using treatment, time variable (day or week), and the interaction as fixed effects and cow or calf(treatment) as a random effect. The term for the repeated statements was the time variable (day or week), with cow or calf(treatment) as the subject. Pen was used as the experimental unit for feed intake and efficiency data. Data were analyzed using treatment, week, and the interaction as fixed effects and pen(treatment) as the random effect. The term for the repeated statements was week and pen(treatment) was the subject. Binomial data (e.g., morbidity) were analyzed using the GLIMMIX procedure of SAS to produce a binomial model with calf as the experimental unit, treatment as a fixed effect, and calf(treatment) as a random effect. Statistical significance was indicated at P ≤ 0.05, and a tendency was indicated when P > 0.05 and ≤0.10.
RESULTS
Cow Performance
Cow BCS data are included in Table 2 . There was no difference (P = 0.82) in cow BCS across treatments after separation on d 56. Cows from both treatments numerically increased in BCS after separation; however, there was no difference in BCS change between NF and CON treatments (P = 0.92). There was also no difference (P = 0.98) in cow pregnancy rate to AI in the subsequent year.
Calf Performance
As seen in Table 3 , there was no difference (P = 0.61) in calf BW between NF and CON treatments at the beginning of the study (d -21), and there was no (P = 0.56) treatment × day interaction for BW throughout the study. There was no difference (P = 0.18) in BW between treatments on d 1 or 7 (P = 0.12). However, there was a tendency for CON calves to weigh more on d 14 (P = 0.09) and 21 (P = 0.07) than NF calves, but there was no difference in BW by d 28.
Calves subjected to both treatments gained BW during the study (P < 0.001). Calves from the CON group had greater ADG (P = 0.03) than NF calves from d -21 to 1 (0.9 vs. 0.6 kg/d; SEM 0.1). During the postseparation period and throughout the experimental period (d -21 to 28), there were no differences in ADG (P = 0.23) between treatments (Table 3) . 3 BCS scale was 1 = thin to 9 = obese (Wagner et al., 1988) . There was a day effect (P < 0.0001) but no treatment × day interaction (P = 0.56) for calf BW over time.
Calf Feed Efficiency
Results for DMI and G:F during the 28-d postseparation period from the dam are in Table 4 . There was no (P = 0.35) treatment × week interaction for DMI. Overall DMI for the 4-wk period was similar (P = 0.27) between treatments.
There was no (P = 0.23) treatment × week interaction for G:F. Over the duration of the 28-d postseparation period, there was no difference (P = 0.27) in G:F between NF and CON calves.
Morbidity and Humoral Immune Response
Calf health responses are included in Table 5 . There was no difference (P ≥ 0.45) between NF and CON calves treated for illness either once or 2 or more times during the 28-d postseparation period. Among calves treated once, the cause for treatment was evaluated and compared across treatments. In some instances, there was more than one cause for treatment. There were no differences (P ≥ 0.96) between treatments for percentage of calves treated for respiratory illness, digestive conditions, or lameness. No mortalities occurred in either treatment group.
Serum Titer Concentration
Serum samples were collected to measure humoral antibody titer response to viral vaccination. Serum antibody titer concentrations are reported in Table 6 . Initial serum antibody titer concentrations for BVDV-1 were greater (P < 0.01) for NF calves; therefore, initial BVDV-1 antibody titer was included as a covariate in the BVDV-1 model. A treatment × day interaction was observed for serum antibody concentration for both BVDV-1 and BHV-1 (P < 0.01). There was a tendency (P = 0.08) for NF calves to have higher serum antibody concentration for BVDV-1 on d 1; however, there was no difference (P = 0.23) between treatment by d 14. Control calves had greater (P < 0.01) serum antibody concentration for BVDV-1 on d 28. There was no difference (P ≥ 0.11) in percentage of calves that had reached seroconversion for BVDV-1 by d 1 or 14. However, by d 28, when antibody concentration peaked, more (P = 0.01) CON calves had seroconverted than NF calves.
There were no differences (P = 0.25) between treatments for serum antibody concentration for BHV-1 on d -21. On d 1, CON calves had greater (P < 0.01) serum antibody concentration for BHV-1 and more (P < 0.01) CON calves had seroconverted for BHV-1 than NF calves. However, there was no difference (P ≥ 0.15) in serum antibody concentration or seroconversion rate when antibody titers peaked on d 14. By d 28, serum antibody concentration for BHV-1 was greater (P < 0.05) for CON vs. NF calves, and there was a tendency (P = 0.07) for a greater percentage of CON calves to have seroconverted than NF calves.
Ovalbumin Titer Concentration
As seen in Table 6 , there were differences (P < 0.01) in serum IgG and IgM antibodies to OVA by day, although treatment × day interactions for IgG or IgM were not significant (P ≥ 0.18). Serum IgG antibody concentration was greater (P < 0.05) on d 14 than 0, but there were no differences (P ≥ 0.76) between treatments on either d 14 or 28. Serum IgG antibody concentration increased (P < 0.05) from 0.0 to 3.70 for both treatments from d 1 to 14 and to 3.77 and 3.75 by d 28 for NF and CON calves, respectively. There were no differences (P ≥ 0.76) in serum IgM antibodies to OVA by treatment on d 1 or 14; however, on d 28, CON calves had greater (P = 0.03) serum IgM antibodies than NF calves. 3 There was a week effect (P < 0.0001) but no treatment × week interaction (P = 0.35) for calf DMI over time. 4 There was a week effect (P < 0.0001) but no treatment × week interaction (P = 0.23) for calf G:F over time.
DISCUSSION
During the study, cow performance did not differ across treatments. Although cow BCS was not monitored on d 0, these findings contradict previous studies where BCS improved when calves were early weaned (Myers et al., 1999; Story et al., 2000) . In cows at 4.2 to 4.3 BCS, Myers et al. (1999) observed an increase in cow BCS when calves were weaned at 90 and 152 d compared with calves weaned at 215 d. Cows in the present study were at a moderate BCS of 5.7 ± 0.10 at initiation of the study, which may have left a narrow window for improvement. Nevertheless, Story et al. (2000) observed an increase in BCS among cows with an average BCS of 5.4 to 5.5 when their calves were weaned at 210 vs. 270 d, and also an increase when calves were weaned at 150 vs. 210 d. In the current study, NF calves were prevented from suckling for only a 21-d period, compared with 60 d or more in other studies, which may have been too short of a time to cause a difference in cow BCS.
The decreased calf ADG for NF calves from d -21 to 1 is consistent with previous studies (Haley et al., 2005; Burke et al., 2009 ). Burke et al. (2009) observed similar findings, where calves with nose flaps gained less weight compared with traditionally and fence-line weaned calves during 7 d before weaning; however, ADG was not hindered during the 7-d postseparation period. Haley et al. (2005) also observed suppressed ADG compared with control calves when nose flaps were used for both 3 and 14 d; however, ADG was greater for nose flap-weaned calves during the 7 d after separation compared with traditionally weaned calves. As NF calves in the current study were effectively removed from milk intake 21 d before CON calves and transitioned from their dam's milk and range forage to only range forage, these results were expected. However, the tendency for NF calves to weigh less than CON calves on d 14 and 21 in the current study contradicts a previous study that found no long-term effects of alternative weaning methods (Lambertz et al., 2014) . This may be due to the fact that in the current study, NF calves were removed from milk 21 d earlier than CON calves. In the future, it may be beneficial to add a third treatment that includes separating and weaning calves from their dams at the time nose flaps are applied to remove all calves from milk at the same time and specifically evaluate the stress-related effects of nose flaps on calves.
Dry matter intake did not differ between treatments. This is somewhat contradictory to research conducted by Haley et al. (2005) , who observed that nose flap weaned-calves spent more time eating during the first days after separation than control calves. Similarly, Price et al. (2003) observed fence line-weaned calves spent more time eating during the first 7 d after separation than control calves. Both Price et al. (2003) and Haley et al. (2005) observed control calves spending more time walking than calves subjected to a low-stress weaning alternative. Although behavioral effects were not measured in the current study, weaning method did not have an effect on feed intake or efficiency.
Possible explanations for the lack of difference in morbidity rate could be due to the fact that calves used in the present study were not "high-risk" calves from a health status standpoint and experienced a low morbidity rate. According to the USDA (2013), across the 3 There was a day effect (P < 0.0001) and a treatment × day interaction (P < 0.001) for BVDV over time. 4 There was a day effect (P < 0.0001) and a treatment × day interaction (P < 0.01) for BHV over time.
5 There was a day effect (P < 0.0001) but no treatment × day interaction (P = 0.97) for OVA IgG over time. 6 There was a day effect (P < 0.0001) but no treatment × day interaction (P = 0.18) for OVA IgM over time.
United States, 16.2% of cattle in feed yards with greater than 1,000 animals were treated for respiratory disease, which is double the morbidity rate observed in the current study. Previous researchers observed morbidity rates for traditionally weaned calves during the first 28 d after being placed in the feed yard from 28% (Boyles et al., 2007) to as high as 60.7 to 75.3% (Richeson et al., 2009) . Cows and calves used in this study were on a proactive vaccination program previously discussed and were not commingled with cattle from other sources, as is a common industry practice after weaning, which likely contributed to a reduced morbidity rate. Results may have differed if calves enrolled in the current study had been considered high risk.
Research investigating the interaction between vaccine effectiveness and weaning stress, including weaning methods, is limited. Recent research investigating delaying vaccination until after weaning has helped to shed light on possible explanations for results seen in serum antibody titers herein. In the current study, implementing a NF protocol at the time of the preweaning vaccinations (d -21) reduced antibody titer concentration and decreased the percentage of calves seroconverting to BVDV-1 and BHV-1 up to 28 d after separation from the dam. In addition, Tait et al. (2013) investigated various weaning times with a 2-vaccine protocol with the booster vaccine given an average of 21 d after the initial vaccine. These authors reported that calves weaned at the initial vaccination had a greater antibody titer response to bovine viral diarrhea virus type 2 and increased ADG than calves weaned at the time the booster vaccination was given, indicating that providing the booster vaccination after stress associated with traditional weaning increased antibody titers. As antibody titer and percentage of calves that seroconverted to BVDV-1 and BHV-1 were suppressed in NF calves in the current study, counter to the hypothesis, this may indicate that stress experienced due to removal of nursing may have hindered vaccine effectiveness that was still present 28 d after separation from the dam. Richeson et al. (2008) reported that when vaccines were delayed 14 d after arrival to the feedlot, calves had greater antibody titers compared with calves vaccinated upon arrival, indicating that waiting to vaccinate until after a stressful event (e.g., weaning) may be beneficial. Furthermore, Pollock et al. (1991) suggested that cell-mediated immunity may be a better indicator of immunological status than humoral immunity for calves older than 5 mo of age; however, cell-mediated immunity was not measured in the current study.
There were no differences in IgG antibody titers to OVA between treatments, but IgM antibody titers to OVA differed by treatment on d 28. As OVA is a foreign antigen and not contained in the previous vaccinations for these calves, the immune system is able to create a primary response that mimics that of foreign antigens the calf may encounter once entering the feed yard. Results of the current study, although not consistent across immunoglobulin type, indicate that primary immune response was negatively affected by the presence of nose flaps before separation from the dam.
This study showed 2 unexpected results relative to humoral immune response to vaccination in the NF and CON calves. First, the magnitude of the humoral response to vaccination around weaning was low in both the NF and CON calves for this study. These vaccinations were performed at about 161 and 183 d of age. This should be sufficient time for maternal antibodies to be depleted and minimal interference should have been observed (Munoz-Zanzi et al., 2002) . However, these calves were previously vaccinated with an intranasal modified live vaccine (at 63 d of age) and an intramuscular modified live vaccine (at 93 d of age). It is very possible that these vaccinations resulted in a memory immune response that could have interfered with vaccine virus replication and blunted the rise in antibodies following vaccination around weaning. The second unexpected result was that the CON calves showed higher titers and a higher percent seroconversion compared with NF calves. This was counter to our hypothesis that the NF group would have less overall stress and a better humoral response to vaccination. One possible explanation of this observation is that the NF calves experienced a significant stress event at both vaccination time points: reduced nutritional (i.e., milk) intake at the d -21 vaccination and separation from the dam at the d 1 vaccination. The reduced nutritional intake is supported by the lower ADG in NF calves for the 21-d period following placement of the nose flap. One possible inference from this study is that vaccineinduced humoral immune response is negatively affected at the time of nose flap application.
When developing the study design for this project, we chose to keep the time of separation from the dam constant while changing the time of weaning (removal from nursing the dam) between the 2 treatment groups. The alternative protocol, where the CON group is weaned and separated from the dam at the same time that the nose flaps are placed while leaving the NF calves with the dams for an additional 3 wk, should be investigated. Either way, both weaning and separation from the dam may have detrimental impacts on immunization in beef calves. These concepts should be carefully considered when using a 2-step nose flap weaning program.
In summary, observations after administration of nose flaps for a 21-d period before weaning indicate that there was no effect on calf feed intake, feed efficiency, or morbidity during the postseparation period from the dam. Under conditions of the current experiment, nose flap insertion at 21 d before separation from the dam reduced preseparation ADG. Calf BW after separation were affected by presence of nose flaps. Serum antibody titer concentration and seroconversion to BVDV-1 and BHV-1, as well as primary immune response to a foreign protein, were hindered due to nose flaps being applied at the time of preweaning vaccination, suggesting that stress associated with nose flap use has effects extending after separation from the dam. Additional research addressing interactions between weaning, transportation, stress, and vaccine effectiveness is needed, possibly including a treatment in which calves are separated from dams concurrent with nose flap presence to monitor performance and health parameters in calves. Additionally, a longer postseparation feeding period may be needed to evaluate long-term effects of nose flap devices on feed yard performance and feed efficiency.
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